Skip to content

PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa

PROMISE EBF: Promoting Infant Health and Nutrition in Sub-Saharan Africa: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00397150
Enrollment
2579
Registered
2006-11-08
Start date
2006-11-30
Completion date
2011-04-30
Last updated
2015-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea

Keywords

Infant Nutrition [G06.696.259.750], Infant Care [N02.421.088.120] +, Diarrhea, Infantile [C23.888.821.214.500], Child Health Services [N02.421.143.130] +, Counseling [N02.421.143.303], Growth [G07.574.249] +, Micronutrients [D11.430], Breast Feeding [G06.696.259.750.500]

Brief summary

The objective of the project is to develop and test an intervention to promote exclusive breastfeeding (EBF), to assess its impact on infant health in African contexts where a high prevalence of HIV is a barrier, and to strengthen the evidence base regarding the optimal duration for EBF. Promotion of EBF is the most effective child health intervention currently feasible for implementation at the population level in low-income countries. It can lower infant mortality by 13%, and by an additional 2% were it not for the fact that breastfeeding transmits HIV. Only recently proven to be possible in hot and even dry climates, EBF without even offering water is still little appreciated by mothers or supported by health workers. EBF rates are especially low in Africa but the potential for rapid implementation may be high. A few studies elsewhere suggest that peer counselling can often achieve dramatic increases. Thus the investigators will run the first randomised trial to develop and test models for applying this approach in four African countries and to quantify health benefits, cost-effectiveness, and implications for the health care system. While experts realize that the HIV threat ought not to present much of a biological constraint to promoting EBF, in heavily affected countries it does represent a cultural constraint. Overcoming this will require the development of a safe and effective means of promoting EBF that is HIV-sensitive by taking into account the need to minimise postnatal HIV transmission. Another scientific constraint to the promotion of exclusive breastfeeding for six months, as recommended by the World Health Organization (WHO), is uncertainty about its impact on the micronutrient status of infants. In a substudy, the investigators will carefully follow markers of infant micronutrient status to see how they vary by feeding pattern, including EBF, for a longer period than has been examined previously.

Detailed description

Rationale The single most effective way of saving the lives of millions of young children in developing countries would be the promotion of exclusive breastfeeding (EBF). Over a period of 10 years it could save the lives of an estimated 15 million children. Infants aged 0-5 months who are not breastfed have seven-fold and five-fold increased risks of death from diarrhoea and pneumonia respectively, compared with infants who are exclusively breastfed. At the same age, non-exclusive rather than exclusive breastfeeding results in more than two-fold increased risks of dying from diarrhoea and pneumonia. Lancet 2003; 361: 2226-34 This assertion, and related comments and findings, set out by the Bellagio Child Survival Group in a recent article in the Lancet summarising findings from international research of how best to reduce infant mortality in developing countries, is made despite our limited knowledge of how best to promote EBF. This proposal addresses the urgent need to tackle this limitation. How best to promote EBF needs attention because it will be necessary to secure high rates of support for EBF from young mothers, and we do not currently know the best way to bring this about, particularly in the cultural context of Africa. Unless we can find more effective strategies to combat poor feeding practices in both health facility and community settings, the child mortality rate will continue to be high. Breastfeeding The benefits of breastfeeding and the negative effects of artificial feeding in underprivileged environments were clearly brought to the public attention in the 1970s, backed by increasingly strong scientific support. As a result the International Code of Marketing of Breast-milk Substitutes and subsequent World Health Assembly Resolutions were created in the 1980s to avoid the marketing of infant foods, teats and bottles in ways that could interfere with breastfeeding. In the early 1990s, UNICEF started the Baby-friendly Hospital Initiative (BFHI), which decreased many of the practices in the health care system that had a negative impact on breastfeeding. Together with many of the other child health programmes during these decades these interventions contributed to a reduction in child morbidity and mortality. Exclusive Breastfeeding - An Even Better Version of Breastfeeding EBF means that the infant receives nothing else other than breast milk, not even water. That breastfed children do not need anything besides breast milk, not even water, and not even in hot climates, was discovered in the 1970s. A decade of research confirmed this, followed by an attempt to define breastfeeding into various patterns by WHO. EBF is not a traditional concept; beliefs and practices regarding a wide range of early supplements are common around the world, and often seem to reflect beliefs expressed by early physicians. Nor is it widely understood by health care professionals, given the lack of information on it even in most paediatric basic training. So if EBF is able to lower child mortality by 13%, why is it not promoted on a large scale already today? Two major reasons are: fear of HIV transmission through breast milk and uncertainty about the micronutrient status in children exclusively breastfed for 6 months. Breastfeeding and Risk of HIV Transmission When an HIV-positive mother breastfeeds for 1.5 years or more, this appears to lead to an additional 15% risk of postnatal HIV transmission on average. At a population level the epidemiological evidence is that exclusive breastfeeding should still be promoted even in countries with a high prevalence of HIV. For many HIV positive mothers the risk of transmitting HIV to their children is outweighed by the risk of the infant dying if not breastfed because of the poor socioeconomic and environmental conditions they live in. Limited evidence suggests that for these women and their children EBF is even more important, not just for minimising respiratory and gastrointestinal infections but also perhaps in reducing the risk of HIV transmission. However in reality the HIV epidemic has undermined breastfeeding promotion efforts especially in countries that would benefit the most. In addition, expensive approaches of dealing with HIV have removed the focus from breastfeeding as an inexpensive way of promoting optimal child health. Intervention: Peer Counselling The constraints discussed above have meant that efforts to promote EBF have been rudimentary so far, consisting mainly of the Baby-Friendly Hospital Initiative. But in Africa nearly all such efforts have come almost to a complete standstill in recent years. EBF promotion therefore needs to be reshaped in this era of HIV. The challenge is to urgently put back on track the promotion of exclusive breastfeeding for the benefit of the world's children without losing credibility by doing it indiscriminately. PROMISE will fine-tune and test an upgraded version of EBF-promotion that is HIV-sensitive and do it in four African countries with a high prevalence of HIV where it is most needed. In particular, it will be the first study to deal explicitly with each of these constraints, opening the way for a more widespread and successful promotion of EBF, especially in Africa, ultimately giving back to Africa one of the powerful and cheap interventions to prevent child mortality and morbidity. Peer counselling is a proven cost-effective approach for changing behaviour, for example, preventing HIV infection. Several studies have also examined its impact on breastfeeding behaviour. Based largely on quasi-experimental studies peer counselling was shown to have an impact on the duration of any breastfeeding. Potential Impact This study will provide the first data from a randomised trial on the safety and efficacy of peer counselling as a way of increasing rates of exclusive breastfeeding in the African context. Outcomes include morbidity, growth, and micronutrient status. PROMISE EBF will provide an example to the world of how efforts to promote exclusive breastfeeding and avoid postnatal HIV transmission can be done jointly, and what synergisms may result. Methods employed and costs will be documented and reported on to increase the ease of replication and sustainability. In Africa, there is a growing awareness that strategies must be identified and tested that can lead to the highest possible infant survival rate in the face of the risk of postnatal HIV transmission. In 1997 UNAIDS, WHO and UNICEF changed their policy on HIV and infant feeding, and issued guidelines for implementing this new policy a year later. Whereas previously countries where most infant mortality was due to infection and malnutrition were advised to promote breastfeeding irrespective of the mother's HIV status, the new policy called for individual counselling on the advantages and disadvantages of breastfeeding vs. artificial feeding that would enable mothers to make an informed choice. UNICEF provided free formula at a number of pilot sites. Methodology Design A prospective, multi-center, community-randomised, controlled, experimental design will be used to execute this trial. Randomization A number of over 30 randomisation units should be identified within a reasonable distance from the study office. The randomisation unit varies between sites but will typically be 1-2 villages with an average of 1000 inhabitants (about 35 infants born per year given a birth rate of 3%). Before engaging in the selection of communities, extensive information will be given to community leaders and the rest of the selection process will be done in close collaboration with community leaders. Within the district the suitable communities will be selected and groups considered similar, based on location, urban-rural, and socioeconomic status will be stratified. Care will be taken to allow for 'corridors' between selected communities to be randomised. In each stratum half of the communities will be randomised to intervention and the reminder to control communities. Local community leaders will be further informed about the study. Each of the clusters should be visited and checked for size, for collaborative administrative leaders, and for not sharing important facilities (water supply, market/shop/trading centre, primary school, mosque, church) with any other potential cluster. If both urban and rural clusters are included no less than 30% of each should be included. The complete list of randomisable clusters will be checked and 24 clusters will be randomised in each site, if applicable in the rural/urban strata. The study will be carried out in four African countries, Burkina Faso in French-speaking West Africa, Uganda in East Africa, Zambia in Central Africa and South Africa in Southern Africa. In each country one or more districts have been selected as the intervention sites, Banfora in the South-west of Burkina-Faso, Mbale District in Eastern Uganda, Mazabuka in Southern Province in Zambia and three sites in South Africa: Umlazi in Durban, KwaZulu Natal, Rietvlei in the Eastern Cape and Paarl in the Western Cape. Pregnant women in the randomised communities (= clusters) will be informed about the study and asked if they are willing to participate. If they agree, an enrolment interview will be carried out and based on eligibility criteria the women will or will not be accepted into the study. Sample Size and Power Of the primary outcome measures the decrease in diarrhoea is the most difficult to catch. We have based our sample size calculation on the expected reduction in cases of diarrhoea (at the age of 3 months) over the last two weeks of one third from 12% to 8%. With a 95% confidence interval (alpha error 0.05) and power of 80%, an average number of infants of 35 per randomised community, and a coefficient of variation between the communities of 0.3, we will need to randomise 48 communities in each arm - a total of 96 communities. This will include 420 infants in each arm in each country, a total of 840 children per country and all in all 3360 children studied across the four sites. This sample size will very accurately give us the increase in EBF and be able to document the above decrease in diarrhoea morbidity. Recruitment Procedure The recruitment procedure will be adapted to the local circumstances. In the most common case, each cluster will have a recruiter (pregnancy monitor) who will be a mature woman of good repute living within the cluster. The pregnancy monitors will inform the research centre about pregnant women that may be eligible to participate in the study. A data collector/research assistant will be sent to visit the woman to ascertain eligibility, obtain consent to participate in the study and conduct the recruitment interview. In South Africa, the recruitment of women will be done at the health facility in the antenatal clinic, where a data collector/research assistant will interview the woman to ascertain eligibility, obtain consent to participate in the study and conduct the recruitment interview.

Interventions

BEHAVIORALPeer-support for exclusive breastfeeding

Counselling to support exclusive breastfeeding up to the age of 6 months of age by the use of peer-counsellors in the local community

Sponsors

European Union
CollaboratorOTHER
The Norwegian Programme for Development, Research and Higher Education
CollaboratorOTHER
University of Bergen
CollaboratorOTHER
Université Montpellier
CollaboratorOTHER
Uppsala University
CollaboratorOTHER
Centre Muraz
CollaboratorOTHER
Makerere University
CollaboratorOTHER
University of Zambia
CollaboratorOTHER
University of the Western Cape
CollaboratorOTHER
Centre For International Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Lives in a selected cluster * Is \>= 6 months pregnant * Has no plans to move outside of the cluster within 1 year

Exclusion criteria

* Reduced ability to collaborate for psychological/mental reasons * Severely ill * Has given birth more than 7 days ago * Has given birth less than 7 days ago and it was a multiple birth; or the child has a severe malformation; or death of the mother or the baby.

Design outcomes

Primary

MeasureTime frameDescription
Exclusive Breastfeeding Rates in Burkina Fasoat 3 months of ageThe EBF prevalences (24-h recall) at 12 weeks in the intervention and control clusters.
Infant Morbidity, 2 Week Diarrhoea Prevalenceat 3 months of age
Exclusive Breastfeeding Rates in Ugandaat 3 months of ageThe EBF prevalences (24-h recall) at 12 weeks in the intervention and control clusters.
Exclusive Breastfeeding Rates in South Africaat 3 months of ageThe EBF prevalences based on 24-h recall at 12 weeks in the intervention and control clusters.

Secondary

MeasureTime frame
Per Protocol Analysis of Infant Morbidityat 3 months of age
Growth(up to 6 months of age)
Per Protocol Analysis of EBF Ratesat 3 months of age

Countries

Burkina Faso, South Africa, Uganda, Zambia

Participant flow

Recruitment details

Pregnant women are recruited in their communities.

Participants by arm

ArmCount
Intervention
Peer-counselling for exclusive breastfeeding
1,323
No Intervention
Standard of care
1,256
Total2,579

Baseline characteristics

CharacteristicInterventionNo InterventionTotal
Age, Categorical
<=18 years
1323 Participants1256 Participants2579 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous7 days7 days7 days
Region of Enrollment
Burkina Faso
392 participants402 participants794 participants
Region of Enrollment
South Africa
535 participants485 participants1020 participants
Region of Enrollment
Uganda
396 participants369 participants765 participants
Sex: Female, Male
Female
662 Participants628 Participants1290 Participants
Sex: Female, Male
Male
661 Participants628 Participants1289 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1,3230 / 1,256
serious
Total, serious adverse events
32 / 1,32322 / 1,256

Outcome results

Primary

Exclusive Breastfeeding Rates in Burkina Faso

The EBF prevalences (24-h recall) at 12 weeks in the intervention and control clusters.

Time frame: at 3 months of age

Population: ITT

ArmMeasureValue (NUMBER)
InterventionExclusive Breastfeeding Rates in Burkina Faso310 participants
No InterventionExclusive Breastfeeding Rates in Burkina Faso161 participants
95% CI: [1.33, 3.92]
Primary

Exclusive Breastfeeding Rates in South Africa

The EBF prevalences based on 24-h recall at 12 weeks in the intervention and control clusters.

Time frame: at 3 months of age

Population: ITT

ArmMeasureValue (NUMBER)
InterventionExclusive Breastfeeding Rates in South Africa56 participants
No InterventionExclusive Breastfeeding Rates in South Africa30 participants
95% CI: [1.12, 2.63]
Primary

Exclusive Breastfeeding Rates in Uganda

The EBF prevalences (24-h recall) at 12 weeks in the intervention and control clusters.

Time frame: at 3 months of age

Population: ITT

ArmMeasureValue (NUMBER)
InterventionExclusive Breastfeeding Rates in Uganda323 participants
No InterventionExclusive Breastfeeding Rates in Uganda161 participants
95% CI: [1.7, 2.11]
Primary

Infant Morbidity, 2 Week Diarrhoea Prevalence

Time frame: at 3 months of age

ArmMeasureValue (NUMBER)
InterventionInfant Morbidity, 2 Week Diarrhoea Prevalence104 participants
No InterventionInfant Morbidity, 2 Week Diarrhoea Prevalence101 participants
Secondary

Growth

Time frame: (up to 6 months of age)

Secondary

Per Protocol Analysis of EBF Rates

Time frame: at 3 months of age

Secondary

Per Protocol Analysis of Infant Morbidity

Time frame: at 3 months of age

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026